1999
DOI: 10.1111/j.1651-2227.1999.tb00070.x
|View full text |Cite
|
Sign up to set email alerts
|

Asymptomatic a‐ketoadipic aciduria detected during a pilot study of neonatal urine screening

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
5
0

Year Published

2009
2009
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 14 publications
0
5
0
Order By: Relevance
“…In human, elevated levels of 2-aminoadipate has been found in infants with metabolic disease, which is caused by a defect in the oxidative decarboxylation of 2-oxoadipate, a catabolic intermediate of lysine, tryptophan, and hydroxylysine . It has been previously reported that 5 out of 7 children with an elevated level of 2-aminoadipate presented with psychomotor retardation . Additionally, 2-aminoadipate has been shown to relate to neurological disorders, such as seizures and convulsions .…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…In human, elevated levels of 2-aminoadipate has been found in infants with metabolic disease, which is caused by a defect in the oxidative decarboxylation of 2-oxoadipate, a catabolic intermediate of lysine, tryptophan, and hydroxylysine . It has been previously reported that 5 out of 7 children with an elevated level of 2-aminoadipate presented with psychomotor retardation . Additionally, 2-aminoadipate has been shown to relate to neurological disorders, such as seizures and convulsions .…”
Section: Discussionmentioning
confidence: 99%
“…44 It has been previously reported that 5 out of 7 children with an elevated level of 2-aminoadipate presented with psychomotor retardation. 45 Additionally, 2-aminoadipate has been shown to relate to neurological disorders, such as seizures and convulsions. Likewise, this metabolite has also been found in increased concentrations in the urine of experimental animals treated with the steatotic hepatotoxin hydrazine.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…An additional search was performed in Pubmed with the search terms: “metabolite name” AND urin* AND concentration AND (newborn* OR neonate* OR infant*) AND (NICU or “neonatal intensive care unit, accessed on 30 May 2023). The concentration values (when available) were included in the Supplementary Table S2 [ 6 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 ]. Notably for 37 metabolites measured in this study, there were no existing literature reports on urinary concentration levels (quantitative results) in newborns or infants under the selected criteria.…”
Section: Resultsmentioning
confidence: 99%
“…The following supporting information can be downloaded at: , Table S1: Compound classification; Table S2: Urinary concentration values for NICU newborns and reference values found in HMDB ( , accessed on 30 May 2023) and Pubmed ( , accessed on 30 May 2023) [ 6 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 ]; Table S3: Perinatal characteristics and maternal history of newborns diagnosed with BPD and non-BPD newborns; Table S4: Fold Changes (FC) for Healthy vs. NICU newborns. Table S5: Pathway analysis: healthy vs. NICU newborns; Figure S1: Volcano plot comparison of BPD newborns (cesarean vs. va, c/v).…”
mentioning
confidence: 99%